https://www.selleckchem.com/pr....oducts/rituximab.htm
Canonical transforming growth factor-beta (TGF-β) signaling exerts neuroprotection and influences memory formation and synaptic plasticity. It has been considered as a new target for the prevention and treatment of depression. This study aimed to examine its modulatory role in linking prenatal maternal depressive symptoms and the amygdala volumes from birth to 6 years of age. We included mother-child dyads (birth n = 161; 4.5 years n = 131; 6 years n = 162) and acquired structural brain images of children at these three time points. P
Like
Comment
Share
